Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT04547439
PHASE2

Sleep, Diabetic Retinopathy and Melatonin

Sponsor: University of Illinois at Chicago

View on ClinicalTrials.gov

Summary

This study explores the use of melatonin in patients with diabetic retinopathy

Official title: Sleep and Circadian Regulation in Diabetic Retinopathy: The Role of Intrinsically Photosensitive Retinal Ganglion Cells and Melatonin Supplementation

Key Details

Gender

All

Age Range

40 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

42

Start Date

2021-02-03

Completion Date

2026-06

Last Updated

2025-08-12

Healthy Volunteers

No

Interventions

DRUG

Melatonin

Melatonin 3 mg will be taken nightly for 8 weeks

OTHER

Placebo

Placebo will be given nightly for 8 weeks

Locations (1)

University of Illinois at Chicago

Chicago, Illinois, United States